Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Bionano's Third Quarter 2023 Earnings Conference Call. Today's conference is being recorded.
Stay updated with breaking news from Human Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, and welcome to the Bionano's Third Quarter 2023 Earnings Conference Call. Today's conference is being recorded.
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Nov 4, 2023--
Expanding the clinical use of RNA sequencing improves diagnostic yield, reduces inconclusive rates, and improves health equityALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., unveiled at the American Society of Human Genetics (A...
Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid-;called phenylalanine (Phe)-;to build up in the bloodstream.
This study in 139 patients with PMM2-CDG represents the largest prospective natural history dataset with more than 300 patient-years of data collected to dateData from this study lay the groundwork for future investigations into potential genotype/phenotype correlationsThe data presented at ASHG 2023 explores the im...